Fate Therapeutics Inc (FATE)

Investing Cash Flow

$87.05M

TTM · Period ending: · USD

FATE logo

FATE Investing Cash Flow

Latest reported$87.05M
FATE TTM Cash from Investing (-$238.00K → $87.05M)
High-resolution chart · PNG

FATE investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Fate Therapeutics Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
87,046,000
92,080,000
111,166,000
106,352,000
110,541,000
37,577,000
12,218,000
34,755,000
34,099,000
120,639,000
112,665,000
120,424,000
175,997,000
183,117,000
166,751,000
184,917,000
182,498,000
140,839,000
-324,023,000
-561,330,000
-693,430,000
-656,738,000
-161,076,000
-105,563,000
-15,136,000
-142,433,000
-157,453,000
-30,554,000
-53,564,000
52,135,000
-463,000
-3,643,000
-3,281,000
-15,664,000
-10,196,000
-17,421,000
-30,601,000
-26,146,000
-4,114,000
-10,270,000
-11,383,000
-17,390,000
-1,498,000
-1,591,000
-1,123,000
-936,000
-882,000
-761,000
-591,000
-629,000
-238,000
-383,000
-721,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.